IGC - InvestorNewsBreaks - IGC Pharma Inc. (NYSE American: IGC) to Attend Investor Summit
IGC Pharma (NYSE American: IGC) (aka India Globalization Capital Inc.) today announced that its Chief Executive Officer Ram Mukunda and Principle Financial Officer Claudia Grimaldi will attend the Investor Summit on Wednesday, March 29, 2023. According to the update, Mukunda and Grimaldi will deliver a virtual company presentation at 11:30 a.m. ET and be available for virtual one-on-one meetings throughout the day. Interested investors should visit https://ibn.fm/AiqIk to register for the webinar and view the live presentation.
To view the full press release, visit https://ibn.fm/4LK0L
About IGC Pharma Inc.
IGC Pharma is a clinical stage biotechnology company developing advanced cannabinoid-based formulations for treating diseases and conditions including Alzheimer’s, dysmenorrhea, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease: IGC-AD1 and TGR-63. IGC-AD1, currently advancing through a phase 2 safety and efficacy clinical trial as a treatment for agitation in dementia due to Alzheimer’s (clinicaltrials.gov, NCT05543681). IGC Pharma is committed to developing impactful drug formulations that meaningfully improve the life of patients suffering from a broad range of diseases and conditions. For more information visit www.IGCPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to IGC are available in the company’s newsroom at https://ibn.fm/IGC
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.